Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Asaumi, N; Omoto, E; Mahmut, N; Katayama, Y; Takeda, K; Shinagawa, K; Harada, M
   Very late antigen-5 and leukocyte function-associated antigen-1 are critical for early stage hematopoietic progenitor cell homing
   ANNALS OF HEMATOLOGY
   
   N. Asaumi et al., "Very late antigen-5 and leukocyte function-associated antigen-1 are critical for early stage hematopoietic progenitor cell homing", ANN HEMATOL, 80(7), 2001, pp. 387-392
2. Asou, N; Adachi, K; Tamura, J; Kanamaru, A; Kageyama, S; Hiraoka, A; Omoto, E; Akiyama, H; Tsubaki, K; Saito, K; Kuriyama, K; Oh, H; Kitano, K; Miyawaki, S; Takeyama, K; Yamada, O; Nishikawa, K; Takahashi, M; Matsuda, S; Ohtake, S; Ohno, R
   Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   N. Asou et al., "Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)", CANC CHEMOT, 48, 2001, pp. S65-S71
3. Yano, T; Katayama, Y; Sunami, K; Ishimaru, F; Shinagawa, K; Ikeda, K; Omoto, E; Niiya, K; Harada, M
   Granulocyte colony-stimulating factor and lineage-independent modulation of VLA-4 expression on circulating CD34(+) cells
   INTERNATIONAL JOURNAL OF HEMATOLOGY
   
   T. Yano et al., "Granulocyte colony-stimulating factor and lineage-independent modulation of VLA-4 expression on circulating CD34(+) cells", INT J HEMAT, 71(4), 2000, pp. 328-333
4. Nawa, Y; Teshima, T; Sunami, K; Hiramatsu, Y; Maeda, Y; Yano, T; Shinagawa, K; Ishimaru, F; Omoto, E; Harada, M
   G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function
   BONE MARROW TRANSPLANTATION
   
   Y. Nawa et al., "G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function", BONE MAR TR, 25(10), 2000, pp. 1035-1040
5. Miyawaki, S; Tanimoto, M; Kobayashi, T; Minami, S; Tamura, J; Omoto, E; Kuriyama, K; Hatake, K; Saito, K; Kanamaru, A; Oh, H; Ohtake, S; Asou, N; Sakamaki, H; Yamada, O; Jinnai, I; Tsubaki, K; Takeyama, K; Hiraoka, A; Matsuda, S; Takahashi, M; Shimazaki, C; Adachi, K; Kageyama, S; Sakura, T; Ohno, R
   No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study
   INTERNATIONAL JOURNAL OF HEMATOLOGY
   
   S. Miyawaki et al., "No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study", INT J HEMAT, 70(2), 1999, pp. 97-104
6. Miyawaki, S; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Yoshida, M; Minami, S; Minato, K; Tsubaki, K; Omoto, E; Oh, H; Jinnai, I; Sakamaki, H; Hiraoka, A; Kanamura, A; Takahashi, I; Saito, K; Naoe, T; Yamada, O; Asou, N; Kageyama, S; Emi, N; Ueda, T; Tomonaga, M; Saito, H; Ueda, R; Ohno, R
   Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
   INTERNATIONAL JOURNAL OF HEMATOLOGY
   
   S. Miyawaki et al., "Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy", INT J HEMAT, 70(1), 1999, pp. 56-57
7. Katayama, Y; Mahmut, N; Takimoto, H; Maeda, Y; Yano, T; Kojima, K; Azuma, T; Hara, M; Imajyo, K; Takahashi, S; Kai, T; Ohno, Y; Miyamoto, T; Nagafuji, K; Matsue, K; Takenaka, K; Teshima, T; Shinagawa, K; Ishimaru, F; Omoto, E; Harada, M
   Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period
   BONE MARROW TRANSPLANTATION
   
   Y. Katayama et al., "Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period", BONE MAR TR, 23(7), 1999, pp. 659-665
8. Nawa, Y; Takenaka, K; Shinagawa, K; Deguchi, S; Matsumura, N; Koyama, S; Hiramatsu, Y; Omoto, E; Yoshino, T; Harada, M
   Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation
   BONE MARROW TRANSPLANTATION
   
   Y. Nawa et al., "Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation", BONE MAR TR, 23(12), 1999, pp. 1321-1322
9. Kiyoi, H; Naoe, T; Nakano, Y; Yokota, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Jinnai, I; Shimazaki, C; Akiyama, H; Saito, K; Oh, H; Motoji, T; Omoto, E; Saito, H; Ohno, R; Ueda, R
   Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
   BLOOD
   
   H. Kiyoi et al., "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia", BLOOD, 93(9), 1999, pp. 3074-3080
10. Takeuchi, M; Yano, T; Omoto, E; Takahashi, K; Kibata, M; Shudo, K; Harada, M; Ueda, R; Ohno, R
    Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: Clinical experience with a new synthetic retinoid, Am-80
    LEUKEMIA & LYMPHOMA
    
    M. Takeuchi et al., "Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: Clinical experience with a new synthetic retinoid, Am-80", LEUK LYMPH, 31(5-6), 1998, pp. 441-451
11. KOJIMA K; OMOTO E; HARA M; SASAKI K; KATAYAMA Y; NAWA Y; KIMURA Y; AZUMA T; TAKIMOTO H; HARADA M
    MYELODYSPLASTIC SYNDROME WITH TRANSLOCATION(8-21) - A DISTINCT MYELODYSPLASTIC SYNDROME ENTITY OR M2-ACUTE MYELOID-LEUKEMIA WITH EXTENSIVE MYELOID MATURATION
    Annals of hematology
    
    K. Kojima et al., "MYELODYSPLASTIC SYNDROME WITH TRANSLOCATION(8-21) - A DISTINCT MYELODYSPLASTIC SYNDROME ENTITY OR M2-ACUTE MYELOID-LEUKEMIA WITH EXTENSIVE MYELOID MATURATION", Annals of hematology, 76(6), 1998, pp. 279-282
12. KATAYAMA Y; TAKENAKA K; MAHMUT N; TESHIMA T; SHINAGAWA K; OMOTO E; HARADA M
    REPLATING POTENTIAL OF COLONY-FORMING-UNITS OF GRANULOCYTES MACROPHAGES (CFU-GM) EXPANDED EX-VIVO BY STEM-CELL FACTOR, INTERLEUKIN (IL)-3, IL-6, GRANULOCYTE-COLONY-STIMULATING FACTOR, ERYTHROPOIETIN WITH OR WITHOUT THROMBOPOIETIN/
    International journal of hematology
    
    Y. Katayama et al., "REPLATING POTENTIAL OF COLONY-FORMING-UNITS OF GRANULOCYTES MACROPHAGES (CFU-GM) EXPANDED EX-VIVO BY STEM-CELL FACTOR, INTERLEUKIN (IL)-3, IL-6, GRANULOCYTE-COLONY-STIMULATING FACTOR, ERYTHROPOIETIN WITH OR WITHOUT THROMBOPOIETIN/", International journal of hematology, 68(2), 1998, pp. 157-168
13. HARA M; SHINAGAWA K; OMOTO E; SUNAMI K; DEGUCHI S; NARUMI H; KOJIMA K; AZUMA T; TAKAMATSU H; NAKAO S; HARADA M
    GRAFT-REJECTION AND RECOVERY OF HOST-DERIVED HEMATOPOIESIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATION TO CONDITIONING WITH HIGH-DOSE ETOPOSIDE AND TOTAL-BODY IRRADIATION
    International journal of hematology
    
    M. Hara et al., "GRAFT-REJECTION AND RECOVERY OF HOST-DERIVED HEMATOPOIESIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATION TO CONDITIONING WITH HIGH-DOSE ETOPOSIDE AND TOTAL-BODY IRRADIATION", International journal of hematology, 68(1), 1998, pp. 95-100
14. KOJIMA K; TANIWAKI M; YOSHINO T; KATAYAMA Y; SUNAMI K; FUKUDA S; OMOTO E; HARADA M; SEZAKI T
    TRISOMY-12 AND T(14-18) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    International journal of hematology
    
    K. Kojima et al., "TRISOMY-12 AND T(14-18) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA", International journal of hematology, 67(2), 1998, pp. 199-203
15. ASOU N; ADACHI K; TAMURA J; KANAMARU A; KAGEYAMA S; HIRAOKA A; OMOTO E; AKIYAMA H; TSUBAKI K; SAITO K; KURIYAMA K; OH H; KITANO K; MIYAWAKI S; TAKEYAMA K; YAMADA O; NISHIKAWA K; TAKAHASHI M; MATSUDA S; OHTAKE S; SUZUSHIMA H; EMI N; OHNO R
    ANALYSIS OF PROGNOSTIC FACTORS IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTICLEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY
    Journal of clinical oncology
    
    N. Asou et al., "ANALYSIS OF PROGNOSTIC FACTORS IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTICLEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY", Journal of clinical oncology, 16(1), 1998, pp. 78-85
16. KATAYAMA Y; DEGUCHI S; SHINAGAWA K; TESHIMA T; NOTOHARA K; TAGUCHI K; OMOTO E; HARADA M
    BONE-MARROW NECROSIS IN A PATIENT WITH ACUTE MYELOBLASTIC-LEUKEMIA DURING ADMINISTRATION OF G-CSF AND RAPID HEMATOLOGIC RECOVERY AFTER ALLOTRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS
    American journal of hematology
    
    Y. Katayama et al., "BONE-MARROW NECROSIS IN A PATIENT WITH ACUTE MYELOBLASTIC-LEUKEMIA DURING ADMINISTRATION OF G-CSF AND RAPID HEMATOLOGIC RECOVERY AFTER ALLOTRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS", American journal of hematology, 57(3), 1998, pp. 238-240
17. Kojima, K; Inoue, Y; Katayama, Y; Kataoka, M; Sunami, K; Fukuda, S; Sezaki, T; Omoto, E; Harada, M
    Improvement with disodium cromoglycate of neutrophil phagocytosis and respiratory burst activity in a patient with hyperimmunoglobulin E syndrome
    ALLERGY
    
    K. Kojima et al., "Improvement with disodium cromoglycate of neutrophil phagocytosis and respiratory burst activity in a patient with hyperimmunoglobulin E syndrome", ALLERGY, 53(11), 1998, pp. 1101-1103
18. ISOKAWA M; KIMURA F; MATSUKI T; OMOTO E; OTSUKA K; KUROKAWA H; TOGAMI I; HIRAKI Y; KIMURA I; HARADA M
    EVALUATION OF BONE-MARROW IRON BY MAGNETIC-RESONANCE-IMAGING
    Annals of hematology
    
    M. Isokawa et al., "EVALUATION OF BONE-MARROW IRON BY MAGNETIC-RESONANCE-IMAGING", Annals of hematology, 74(6), 1997, pp. 269-274
19. YANO T; KATAYAMA Y; SUNAMI K; DEGUCHI S; NAWA Y; HIRAMATSU Y; NAKAYAMA H; ARAKAWA T; ISHIMARU F; TESHIMA T; SHINAGAWA K; OMOTO E; HARADA M
    G-CSF-INDUCED MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR ALLOGRAFTING - COMPARATIVE-STUDY OF DAILY SINGLE VERSUS DIVIDED DOSE OF G-CSF
    International journal of hematology
    
    T. Yano et al., "G-CSF-INDUCED MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR ALLOGRAFTING - COMPARATIVE-STUDY OF DAILY SINGLE VERSUS DIVIDED DOSE OF G-CSF", International journal of hematology, 66(2), 1997, pp. 169-178
20. YUASA H; HAMAJIMA N; UEDA R; OHNO R; ASOU N; UTSUNOMIYA A; OGURA M; TAKIGAWA N; UEDA T; HIRAOKA A; MATSUDA S; KURAISHI Y; NISHIKAWA K; UIKE N; TAKESHITA A; TAKEMOTO Y; SHIMAZAKI C; SAKAMAKI H; INO T; MATSUSHIMA T; KURIYAMA K; HIRAI H; NAOE T; TSUBAKI K; TAKAHASHI M; TAKEYAMA K; MORISHIMA Y; ITOH K; OMOTO E; HODOHARA K; TAKAHASHI I
    CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE
    International journal of hematology
    
    H. Yuasa et al., "CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE", International journal of hematology, 65(3), 1997, pp. 251-261
21. BESSHO M; HIRASHIMA K; ASANO S; IKEDA Y; OGAWA N; TOMONAGA M; TOYAMA K; NAKAHATA T; NOMURA T; MIZOGUCHI H; YOSHIDA Y; NIITSU Y; KOHGO Y; MIYAZAKI T; TAKAMI H; MIURA AB; SASAKI H; ABE K; KURIYA S; SHIGA Y; SHIBATA A; HAYASHI N; MURAKAMI H; MIYAWAKI S; ENOKIHARA H; TAKEMURA Y; MIURA Y; TAKAGI S; TOYA K; KOBAYASHI I; KOMIYAMA A; MITSUHASHI S; MOTOYOSHI K; SAKURAI M; OHTA M; YOSHIDA S; HIGASHIHARA M; HIRAI H; MORI M; MUTO Y; HIROSAWA S; HIROSE S; OHSHIMA T; TSURUOKA N; OMINE M; TSUKIMOTO I; ONOZAWA Y; AOKI I; TSUNEMATSU Y; KAWATO M; YABE H; KITAHARA M; MATSUYAMA S; AKATSUKA N; HIRASAWA A; AOYAGI Y; NISHIHIRA H; HIRANO M; HOTTA T; KODERA Y; KOJIMA S; MINAMI N; OHTAKA S; TAKIGUCHI T; NAKAMURA T; FUJIYAMA Y; SUZUKI T; AKIYAMA Y; NAKAGAWA M; MISAWA S; HIBI S; FUJII H; MATSUZAWA Y; KISHIMOTO T; KITANI T; OHSAWA N; TATSUMI N; KISHIDA T; HIRAOKA A; KAWA K; NII M; KONISHI S; FUKUHARA S; HORIUCHI A; KAKISHITA E; MATSUI T; ISHIKAWA T; OMOTO E; YAWATA Y; KOBAYASHI M; KURAMOTO A; DOHY H; KANEKO T; SHINOHARA K; TAGUCHI H; UCHIDA T; TANAKA T; KOSAKA M; NIHO Y; UEDA K; ETO S; MIYAZAKI S; AMENOMORI M; KAWAKITA M; NISHIMURA H; UIKE N; NATORI H; IKEDA S; TAMURA K
    TREATMENT OF THE ANEMIA OF APLASTIC-ANEMIA PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER RANDOMIZED CONTROLLED-STUDY
    European journal of haematology
    
    M. Bessho et al., "TREATMENT OF THE ANEMIA OF APLASTIC-ANEMIA PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER RANDOMIZED CONTROLLED-STUDY", European journal of haematology, 58(4), 1997, pp. 265-272
22. MATSUO Y; MACLEOD RAF; UPHOFF CC; DREXLER HG; NISHIZAKI C; KATAYAMA Y; KIMURA G; FUJII N; OMOTO E; HARADA M; ORITA K
    2 ACUTE MONOCYTIC LEUKEMIA (AML-M5A) CELL-LINES (MOLM-13 AND MOLM-14)WITH INTERCLONAL PHENOTYPIC HETEROGENEITY SHOWING MLL-AF9 FUSION RESULTING FROM AN OCCULT CHROMOSOME INSERTION, INS(11-9)(Q23-P22P23)
    Leukemia
    
    Y. Matsuo et al., "2 ACUTE MONOCYTIC LEUKEMIA (AML-M5A) CELL-LINES (MOLM-13 AND MOLM-14)WITH INTERCLONAL PHENOTYPIC HETEROGENEITY SHOWING MLL-AF9 FUSION RESULTING FROM AN OCCULT CHROMOSOME INSERTION, INS(11-9)(Q23-P22P23)", Leukemia, 11(9), 1997, pp. 1469-1477
23. KATAYAMA Y; TAKIMOTO H; FUJII N; KIMURA G; OMOTO E; HARADA M
    CLONAL EVOLUTION TO ACUTE MYELOBLASTIC-LEUKEMIA WITH MLL GENE REARRANGEMENT FROM TRISOMY-8 CLONE
    Leukemia
    
    Y. Katayama et al., "CLONAL EVOLUTION TO ACUTE MYELOBLASTIC-LEUKEMIA WITH MLL GENE REARRANGEMENT FROM TRISOMY-8 CLONE", Leukemia, 11(8), 1997, pp. 1380-1382
24. OHNO R; MIYAWAKI S; HATAKE K; KURIYAMA K; SAITO K; KANAMARU A; KOBAYASHI T; KODERA Y; NISHIKAWA K; MATSUDA S; YAMADA O; OMOTO E; TAKEYAMA H; TSUKUDA K; ASOU N; TANIMOTO M; SHIOZAKI H; TOMONAGA M; MASAOKA T; MIURA Y; TAKAKU F; OHASHI Y; MOTOYOSHI K
    HUMAN URINARY MACROPHAGE-COLONY-STIMULATING FACTOR REDUCES THE INCIDENCE AND DURATION OF FEBRILE NEUTROPENIA AND SHORTENS THE PERIOD REQUIRED TO FINISH 3 COURSES OF INTENSIVE CONSOLIDATION THERAPY IN ACUTE MYELOID-LEUKEMIA - A DOUBLE-BLIND CONTROLLED-STUDY
    Journal of clinical oncology
    
    R. Ohno et al., "HUMAN URINARY MACROPHAGE-COLONY-STIMULATING FACTOR REDUCES THE INCIDENCE AND DURATION OF FEBRILE NEUTROPENIA AND SHORTENS THE PERIOD REQUIRED TO FINISH 3 COURSES OF INTENSIVE CONSOLIDATION THERAPY IN ACUTE MYELOID-LEUKEMIA - A DOUBLE-BLIND CONTROLLED-STUDY", Journal of clinical oncology, 15(8), 1997, pp. 2954-2965
25. ASOU N; ADACHI K; TAMURA J; KANAMARU A; KAGEYAMA S; HIRAOKA A; OMOTO E; SAKAMAKI H; TSUBAKI K; SAITO K; OHNO R
    ALL-TRANS-RETINOIC ACID THERAPY FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - COMPARISON WITH INTENSIVE CHEMOTHERAPY
    Cancer chemotherapy and pharmacology
    
    N. Asou et al., "ALL-TRANS-RETINOIC ACID THERAPY FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - COMPARISON WITH INTENSIVE CHEMOTHERAPY", Cancer chemotherapy and pharmacology, 40, 1997, pp. 30-35
26. HARADA M; SUNAMI K; NAWA Y; HIRAMATSU Y; TESHIMA T; SHINAGAWA K; OMOTO E
    ANALYSIS OF FUNCTIONS OF T-CELLS AND MONOCYTES IN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    Experimental hematology
    
    M. Harada et al., "ANALYSIS OF FUNCTIONS OF T-CELLS AND MONOCYTES IN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS", Experimental hematology, 25(8), 1997, pp. 269-269
27. KATAYAMA Y; YANO T; BESSHO A; DEGUCHI S; SUNAMI K; MAHMUT N; SHINAGAWA K; OMOTO E; MAKINO S; MIYAMOTO T; MIZUNO S; FUKUDA T; ETO T; FUJISAKI T; OHNO Y; INABA S; NIHO Y; HARADA M
    THE EFFECTS OF A SIMPLIFIED METHOD FOR CRYOPRESERVATION AND THAWING PROCEDURES ON PERIPHERAL-BLOOD STEM-CELLS
    Bone marrow transplantation
    
    Y. Katayama et al., "THE EFFECTS OF A SIMPLIFIED METHOD FOR CRYOPRESERVATION AND THAWING PROCEDURES ON PERIPHERAL-BLOOD STEM-CELLS", Bone marrow transplantation, 19(3), 1997, pp. 283-287
28. KATAYAMA Y; KOJIMA K; YOSHINO T; MATSUO Y; ISOKAWA M; YANO T; OKA H; YAMAGUCHI M; DEGUCHI S; TSUCHIYAMA J; HAYASHI K; TESHIMA T; SHINAGAWA K; ISHIMARU F; OMOTO E; HARADA M
    COMMON CLONAL ORIGIN OF LYMPHOCYTES AND PLASMA-CELLS IN SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES
    British Journal of Haematology
    
    Y. Katayama et al., "COMMON CLONAL ORIGIN OF LYMPHOCYTES AND PLASMA-CELLS IN SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES", British Journal of Haematology, 97(3), 1997, pp. 626-634
29. TAKEUCHI M; YANO T; OMOTO E; TAKAHASHI K; KIBATA M; SHUDO K; UEDA R; OHNO R; HARADA M
    RE-INDUCTION OF COMPLETE REMISSION WITH A NEW SYNTHETIC RETINOID, AM-80, FOR RELAPSE OF ACUTE PROMYELOCYTIC LEUKEMIA PREVIOUSLY TREATED WITH ALL-TRANS-RETINOIC ACID
    British Journal of Haematology
    
    M. Takeuchi et al., "RE-INDUCTION OF COMPLETE REMISSION WITH A NEW SYNTHETIC RETINOID, AM-80, FOR RELAPSE OF ACUTE PROMYELOCYTIC LEUKEMIA PREVIOUSLY TREATED WITH ALL-TRANS-RETINOIC ACID", British Journal of Haematology, 97(1), 1997, pp. 137-140
30. NAWA Y; TESHIMA T; SUNAMI K; HIRAMATSU Y; YANO T; SHINAGAWA K; OMOTO E; HARADA M
    RESPONSES OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO ALLOANTIGEN STIMULATION
    Blood
    
    Y. Nawa et al., "RESPONSES OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO ALLOANTIGEN STIMULATION", Blood, 90(4), 1997, pp. 1716-1718
31. KATAYAMA Y; MAHMUT N; TAKIMOTO H; MAEDA Y; YANO T; KOJIMA K; AZUMA T; HARA M; TSUCHIYAMA J; TAKABA S; IMAJYO K; TANAKA H; TAKAHASHI S; KAI T; OHNO Y; MIYAMOTO T; NAGAFUJI K; MATSUE K; TAKENAKA K; TESHIMA T; SHINAGAWA K; ISHIMARU F; OMOTO E; HARADA M
    PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS FROM ALLOGENEIC BONE-MARROW DONORS CIRCULATE IN VERY EARLY POSTTRANSPLANT PERIOD
    Blood
    
    Y. Katayama et al., "PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS FROM ALLOGENEIC BONE-MARROW DONORS CIRCULATE IN VERY EARLY POSTTRANSPLANT PERIOD", Blood, 90(10), 1997, pp. 4167-4167
32. TESHIMA T; SUNAMI K; BESSHO A; SHINAGAWA K; OMOTO E; UEOKA H; HARADA M; OHNO Y; MIYOSHI T; MIYAMOTO T; HIGUCHI M
    CIRCULATING IMMATURE CELL COUNTS ON THE HARVEST DAY PREDICT THE YIELDS OF CD34(-COLONY-STIMULATING FACTOR PLUS CHEMOTHERAPY-INDUCED MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELL() CELLS COLLECTED AFTER GRANULOCYTE)
    Blood
    
    T. Teshima et al., "CIRCULATING IMMATURE CELL COUNTS ON THE HARVEST DAY PREDICT THE YIELDS OF CD34(-COLONY-STIMULATING FACTOR PLUS CHEMOTHERAPY-INDUCED MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELL() CELLS COLLECTED AFTER GRANULOCYTE)", Blood, 89(12), 1997, pp. 4660-4661
33. KATAYAMA Y; KOJIMA K; OMOTO E; HARADA M
    ANDROGEN THERAPY IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN IN A PATIENT WITH REFRACTORY-ANEMIA
    International journal of hematology
    
    Y. Katayama et al., "ANDROGEN THERAPY IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN IN A PATIENT WITH REFRACTORY-ANEMIA", International journal of hematology, 65(1), 1996, pp. 89-92
34. KOJIMA K; OMOTO E; KATAYAMA Y; UNO M; TAKADA I; KIMURA G; KANEHIRO A; TADA S; HAYASHI K; KIMURA I; SANADA H; HARADA M
    AUTOIMMUNE HEMOLYTIC-ANEMIA IN ALLERGIC GRANULOMATOUS ANGITIS (CHURG-STRAUSS-SYNDROME)
    International journal of hematology
    
    K. Kojima et al., "AUTOIMMUNE HEMOLYTIC-ANEMIA IN ALLERGIC GRANULOMATOUS ANGITIS (CHURG-STRAUSS-SYNDROME)", International journal of hematology, 63(2), 1996, pp. 149-154
35. OMOTO E; DEGUCHI S; TAKABA S; KOJIMA K; YANO T; KATAYAMA Y; SUNAMI K; TAKEUCHI M; KIMURA F; HARADA M; KIMURA I
    LOW-DOSE MELPHALAN FOR TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES
    Leukemia
    
    E. Omoto et al., "LOW-DOSE MELPHALAN FOR TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES", Leukemia, 10(4), 1996, pp. 609-614
36. KATAYAMA Y; KOJIMA K; YOSHINO T; MATSUO Y; ISOKAWA M; YANO T; TESHIMA T; ISHIMARU F; SHINAGAWA K; OMOTO E; HARADA M
    MEMORY B-CELL IN SPLEEN IS THE ORIGIN OF SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES
    Blood
    
    Y. Katayama et al., "MEMORY B-CELL IN SPLEEN IS THE ORIGIN OF SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES", Blood, 88(10), 1996, pp. 945-945
37. OMOTO E; DEGUCHI S; ISOKAWA M; TAKABA S; KOJIMA K; YANO T; KATAYAMA Y; SUNAMI K; TAKEUCHI M; TESHIMA T; SHINAGAWA K; HARADA M
    LOW-DOSE MELPHALAN IS AN EFFECTIVE AND LOW-COST TREATMENT FOR HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH HYPOPLASTIC MARROW
    Blood
    
    E. Omoto et al., "LOW-DOSE MELPHALAN IS AN EFFECTIVE AND LOW-COST TREATMENT FOR HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH HYPOPLASTIC MARROW", Blood, 88(10), 1996, pp. 2312-2312